Six Pharma Cos Get Notice for Overpricing (India)
This article was originally published in PharmAsia News
Executive Summary
India's National Pharmaceutical Pricing Authority (NPAA) has begun taking action against drug companies accused of producing overpriced or unapproved medications. Previously 11 pharmaceutical companies had volunteered to cut prices on 886 drugs. NPAA investigations found that six companies were not complying with the reduction on 58 different medications. They also discovered that 39 unapproved versions the 886 drugs had been made available. (Click here for more